PTGX logo

Protagonist Therapeutics (PTGX) Net Income

Annual Net Income

$275.19 M
+$354.14 M+448.54%

December 31, 2024

Summary

Performance

1-Year Change

+448.54%

3-Year Change

+319.18%

5-Year Change

+456.52%

15-Year Change

+844.62%

PTGX Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

93.04%
PTGX annual net profit is higher than 93.04% of companies in Healthcare sector

High & Low

All-time High

$275.19 M
PTGX annual net profit is currently at an all-time high

3-Year Low

-$127.39 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
PTGX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
PTGX next annual earnings announcement has not yet been scheduled

OtherPTGXprofitabilitymetrics:

Annual Net Margin

63.34%
PTGX annual net profit margin is 63.34%

Annual Revenue

$434.43 M
PTGX annual revenue is $434.43 million

Annual Gross Profit

-
PTGX annual gross profit value is unknown

Annual EPS

$4.23
PTGX annual earnings per share is $4.23

Quarterly Net Income

$131.67 M
+$164.88 M+496.49%

December 31, 2024

Summary

Performance

3-Month Change

+496.49%

1-Year Change

+496.49%

3-Year Change

+496.49%

5-Year Change

+496.49%

PTGX Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

93.86%
PTGX quarterly net profit is higher than 93.86% of companies in Healthcare sector

High & Low

All-time High

$207.34 M
PTGX quarterly net profit is currently -36.49% below its historical high of $207.34 million

3-Year Low

-$41.04 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
PTGX previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 7, 2025
PTGX next earnings announcement is scheduled for May 7, 2025

OtherPTGXprofitabilitymetrics:

Quarterly Net Margin

77.17%
PTGX quarterly net profit margin is 77.17%

Quarterly Revenue

$170.64 M
PTGX quarterly revenue is $170.64 million

Quarterly Gross Profit

-
PTGX quarterly gross profit value is unknown

Quarterly EPS

$1.98
PTGX quarterly earnings per share is $1.98

TTM Net Income

$275.19 M
+$104.34 M+61.07%

December 31, 2024

Summary

Performance

3-Month Change

+61.07%

1-Year Change

+61.07%

3-Year Change

+61.07%

5-Year Change

+61.07%

PTGX TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

92.75%
PTGX TTM net profit is higher than 92.75% of companies in Healthcare sector

High & Low

All-time High

$275.19 M
PTGX TTM net profit is currently at an all-time high

3-Year Low

-$140.48 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
PTGX previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 7, 2025
PTGX next earnings announcement is scheduled for May 7, 2025

OtherPTGXprofitabilitymetrics:

Annual Net Margin

63.34%
PTGX annual net profit margin is 63.34%

TTM Revenue

$434.43 M
PTGX TTM revenue is $434.43 million

TTM Gross Profit

-
PTGX TTM gross profit value is unknown

TTM EPS

$4.20
PTGX TTM earnings per share is $4.20

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

$275.19 M
PTGX annual net profit is $275.19 million

Annual Revenue

$434.43 M
PTGX annual revenue is $434.43 million

Annual Cost Of Goods Sold

-
PTGX annual cost of goods sold value is unknown

Annual Operating Expenses

$181.59 M
PTGX annual total operating expenses is $181.59 million

Annual Interest Expense

-
PTGX annual interest expense value is unknown

Annual Income Tax

$4.22 M
PTGX annual income tax is $4.22 million

PTGX Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+448.5%+496.5%+61.1%
3 y3 years+319.2%+496.5%+61.1%
5 y5 years+456.5%+496.5%+61.1%

PTGX Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+316.0%-36.5%+420.9%at high+295.9%
5 y5-yearat high+316.0%-36.5%+420.9%at high+295.9%
alltimeall timeat high+316.0%-36.5%+420.9%at high+295.9%

Protagonist Therapeutics Net Income History

DateAnnualQuarterlyTTM
Dec 2024
$275.19 M(-448.5%)
$131.67 M(-496.5%)
$275.19 M(+61.1%)
Sep 2024
-
-$33.21 M(+8.5%)
$170.85 M(+0.5%)
Jun 2024
-
-$30.62 M(-114.8%)
$169.95 M(+4.8%)
Mar 2024
-
$207.34 M(+658.5%)
$162.11 M(-305.3%)
Dec 2023
-$78.95 M(-38.0%)
$27.34 M(-180.1%)
-$78.95 M(-43.8%)
Sep 2023
-
-$34.10 M(-11.3%)
-$140.48 M(+2.1%)
Jun 2023
-
-$38.46 M(+14.0%)
-$137.61 M(-1.8%)
Mar 2023
-
-$33.73 M(-1.4%)
-$140.19 M(+10.0%)
Dec 2022
-$127.39 M(+1.5%)
-$34.19 M(+9.5%)
-$127.39 M(-2.1%)
Sep 2022
-
-$31.23 M(-23.9%)
-$130.11 M(-1.9%)
Jun 2022
-
-$41.04 M(+96.1%)
-$132.68 M(+8.3%)
Mar 2022
-
-$20.93 M(-43.3%)
-$122.48 M(-2.4%)
Dec 2021
-$125.55 M(+89.8%)
-$36.91 M(+9.2%)
-$125.55 M(+16.8%)
Sep 2021
-
-$33.80 M(+9.6%)
-$107.53 M(+32.0%)
Jun 2021
-
-$30.84 M(+28.5%)
-$81.49 M(+16.3%)
Mar 2021
-
-$24.00 M(+27.1%)
-$70.07 M(+5.9%)
Dec 2020
-$66.15 M(-14.3%)
-$18.89 M(+143.3%)
-$66.15 M(+2.1%)
Sep 2020
-
-$7.76 M(-60.0%)
-$64.77 M(-11.8%)
Jun 2020
-
-$19.42 M(-3.3%)
-$73.41 M(-11.7%)
Mar 2020
-
-$20.08 M(+14.7%)
-$83.16 M(+7.7%)
DateAnnualQuarterlyTTM
Dec 2019
-$77.19 M(+98.3%)
-$17.50 M(+6.7%)
-$77.19 M(+4.9%)
Sep 2019
-
-$16.41 M(-43.8%)
-$73.55 M(+11.6%)
Jun 2019
-
-$29.17 M(+106.9%)
-$65.88 M(+45.2%)
Mar 2019
-
-$14.10 M(+1.7%)
-$45.37 M(+16.6%)
Dec 2018
-$38.92 M(+5.3%)
-$13.87 M(+58.7%)
-$38.92 M(+38.5%)
Sep 2018
-
-$8.73 M(+0.8%)
-$28.11 M(+16.2%)
Jun 2018
-
-$8.66 M(+13.1%)
-$24.20 M(-20.7%)
Mar 2018
-
-$7.66 M(+151.0%)
-$30.52 M(-17.4%)
Dec 2017
-$36.96 M(-0.6%)
-$3.05 M(-36.7%)
-$36.96 M(-18.2%)
Sep 2017
-
-$4.83 M(-67.8%)
-$45.15 M(-4.8%)
Jun 2017
-
-$14.98 M(+6.2%)
-$47.41 M(+19.9%)
Mar 2017
-
-$14.10 M(+25.4%)
-$39.53 M(+6.3%)
Dec 2016
-$37.18 M(+150.2%)
-$11.25 M(+58.8%)
-$37.18 M(+18.3%)
Sep 2016
-
-$7.08 M(-0.2%)
-$31.42 M(+13.1%)
Jun 2016
-
-$7.10 M(-39.6%)
-$27.79 M(+16.2%)
Mar 2016
-
-$11.75 M(+113.9%)
-$23.91 M(+60.9%)
Dec 2015
-$14.86 M(+34.2%)
-$5.49 M(+59.3%)
-$14.86 M(+58.7%)
Sep 2015
-
-$3.45 M(+7.1%)
-$9.37 M(+58.3%)
Jun 2015
-
-$3.22 M(+19.4%)
-$5.92 M(+119.4%)
Mar 2015
-
-$2.70 M
-$2.70 M
Dec 2014
-$11.07 M
-
-

FAQ

  • What is Protagonist Therapeutics annual net profit?
  • What is the all time high annual net income for Protagonist Therapeutics?
  • What is Protagonist Therapeutics annual net income year-on-year change?
  • What is Protagonist Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Protagonist Therapeutics?
  • What is Protagonist Therapeutics quarterly net income year-on-year change?
  • What is Protagonist Therapeutics TTM net profit?
  • What is the all time high TTM net income for Protagonist Therapeutics?
  • What is Protagonist Therapeutics TTM net income year-on-year change?

What is Protagonist Therapeutics annual net profit?

The current annual net income of PTGX is $275.19 M

What is the all time high annual net income for Protagonist Therapeutics?

Protagonist Therapeutics all-time high annual net profit is $275.19 M

What is Protagonist Therapeutics annual net income year-on-year change?

Over the past year, PTGX annual net profit has changed by +$354.14 M (+448.54%)

What is Protagonist Therapeutics quarterly net profit?

The current quarterly net income of PTGX is $131.67 M

What is the all time high quarterly net income for Protagonist Therapeutics?

Protagonist Therapeutics all-time high quarterly net profit is $207.34 M

What is Protagonist Therapeutics quarterly net income year-on-year change?

Over the past year, PTGX quarterly net profit has changed by +$164.88 M (+496.49%)

What is Protagonist Therapeutics TTM net profit?

The current TTM net income of PTGX is $275.19 M

What is the all time high TTM net income for Protagonist Therapeutics?

Protagonist Therapeutics all-time high TTM net profit is $275.19 M

What is Protagonist Therapeutics TTM net income year-on-year change?

Over the past year, PTGX TTM net profit has changed by +$104.34 M (+61.07%)